Legislative Affairs

“One of the penalties of not participating in politics is that you will be governed by your inferiors.”

Plato

The mission of APCI’s Legislative Affairs division is to promote and protect the political and economic interests of all APCI members. In order to accomplish that mission, Legislative Affairs:

  • Provides lobbyist and/or legislative assistance in all APCI member states
  • Identifies pharmacy-friendly political candidates and generate funding to support them
  • Contributes to state associations and organizations with similar legislative focus
  • Identifies political leaders to meet and key meetings or conferences to attend
  • Establishes routine and structured legislative meetings in each state
  • Leverages APCI account representatives and staff personnel
  • Utilizes APCI's Board of Directors to attend selected legislative events
  • Encourages APCI member participation and support of NCPA
  • Maintains a Washington, D.C., presence, supporting NCPA and developing direct relationships

For more information about APCI's Legistative Affairs division, contact us or call (800) 532-2724.

3

Oct

2016

NCPA Advocacy Center Update 10.3.16

This week's Advocacy Center update includes information on support for federal legislation opposing retroactive DIR fees, a request for a hearing into PBM practices, and more!

30

Sep

2016

Contacts! Contacts! Contacts!

While Congress is back home until November 14th, what better time than to make a CONTACT regarding H.R. 5951 and S. 3308, “Improving Transparence and Accuracy in Medicare Part D Spending Act”?

26

Sep

2016

NCPA Advocacy Center Update 9.26.16

In this week's roundup, learn about growing support for federal DIR legislation, Congressional hearings exposing PBM tactics, and more!

22

Sep

2016

Watch Rep. Buddy Carter grill Mylan CEO on EpiPen pricing

U.S. Rep. Buddy Carter grills Mylan CEO Heather Bresch during a hearing on Capitol Hill.

19

Sep

2016

NCPA Advocacy Center Update 9.19.16

In this week's update, new legislation is introduced in the U.S. Senate to end DIR fees, Optum will meet with pharmacies and wholesalers regarding a new policy on distributor accreditation, and more!

First 56575859 Last